Is Laser Resurfacing Safe for All Skin Types? A Medical Device Procurement Manager’s View

Is Laser Resurfacing Safe for All Skin Types? Not by Default.

I’m the person who signs off on capital equipment for a 14-person dermatology clinic. Over the last seven years, I’ve reviewed more than $1.2 million in laser and energy-device purchases, tracked every service invoice, and sat through enough vendor presentations to be suspicious of one sentence: “This device is safe for all skin types.”

So when someone asks whether laser resurfacing is safe for all skin types, my honest answer is: not by default. A sales rep who gives a fast “yes” is not reassuring me. They are telling me that the conversation is about closing, not about our patients.

Safety in a medical setting is a process, not a feature. A dermatology laser device is only as safe as the patient selection, indication, settings, operator training, and follow-up plan around it. Skip any of those links and the equipment becomes a liability, regardless of the brand name printed on the console.

Why “Universal” Is the Most Expensive Claim in Aesthetics

Here is what makes me nervous: complications rarely appear in a capital budget forecast. A skin rejuvenation laser can look brilliant in a utilization spreadsheet, but one case of post-inflammatory hyperpigmentation in someone with Fitzpatrick skin type IV or V can erase the profit from dozens of routine treatments. That risk is real. It does not show up in the quote.

A few years ago, I evaluated a device with “all skin types” printed all over the brochure. The results photos looked good, but those photos did not tell me how many patients with deeper skin tones were treated, what conditions they started with, or how many dropped out because of side effects. When I asked for the data, the answer got vague. That is the moment I start mentally deleting a vendor from the shortlist.

Regulatory clearance is not a universal safety guarantee either. Clearance for specific indications means a device met the regulatory bar for those indications, not that it is risk-free in every pair of hands. Per FTC advertising guidance (ftc.gov), claims must be truthful, not misleading, and substantiated. I use that as the baseline. Then I apply a stricter procurement rule: if the vendor cannot show the subgroup data before the purchase, they will not produce it after a problem.

Laser resurfacing also covers a wide range of technologies. Ablative systems remove tissue in a more aggressive way; nonablative and fractional systems are generally designed for gentler remodeling, but they are not interchangeable. That is exactly why a universal safety claim makes no sense from an equipment-buying perspective. The machine is only part of the equation. The clinical protocol around it is what makes a procedure defensible.

What I Evaluate in a Dermatology Laser Device

After one expensive lesson, I built a 10-point checklist for every capital purchase over $50,000. The list is not exciting. It keeps me honest.

1. Published outcomes in the skin types we actually treat, not just overall averages.
2. A training plan for every provider who will use the handpiece, not a single lunch-and-learn.
3. A two-year projection of disposables, service contract, calibration, and expected downtime.
4. A remote troubleshooting process that does not leave us waiting for an engineer for two weeks.

That final item is where many evaluations fail. The sticker price is the down payment, not the total cost. I remember comparing two similar systems where the lower-priced unit looked better on paper. The numbers said we would save about $21,000 upfront. My gut said the service contract was too thin. We ran the total cost of ownership anyway, and adding required training plus per-treatment consumables made the “cheaper” device $7,400 more expensive over 24 months. The spreadsheet found what the sales deck was hiding.

The upside of the cheaper price was real, at least on paper. The risk was that we would save $21,000 in year one but spend the next two years managing a device with no local support. I kept asking myself whether that trade-off was worth it. It was not. Now we run the same calculation for every purchase, and I document every assumption in our cost tracking system.

The frustrating part is that those expensive mistakes are avoidable. You might expect a regulated medical device purchase to include mandatory verification steps. It does not. That is why the checklist has to live in our purchasing process instead of in a manufacturer brochure.

Why Solta Medical Clear and Brilliant Keeps Showing Up in My Reviews

People sometimes ask whether the Solta Medical logo is worth a premium. I think that is the wrong question. A logo is not a guarantee of perfect outcomes. It is a signal of traceability. In procurement, traceability matters because we need someone who still answers the phone after the sale, someone who supplies training materials, and someone who can talk us through a complication instead of disappearing.

Solta Medical Clear and Brilliant is the device I keep returning to for preventative skin maintenance. It gives our team a lower-risk entry point for patients who are not ready for a more aggressive resurfacing procedure. Fraxel and Thermage sit in different parts of the market, but they share something useful: a manufacturer that treats safety as a protocol conversation, not a one-word answer.

When Solta Medical Clear and Brilliant is the right recommendation, we still choose patients carefully, start with conservative settings, and take baseline photos. That is not bureaucracy. It is the cheapest insurance I know. A branded device makes the process easier, but it never replaces the process.

At the same time, we don’t expect any single skin rejuvenation laser to be perfect for everyone. We need a laser to do the job we bought it for, repeatedly, without surprises. That expectation holds whether the box has the Solta Medical logo or not.

The Prevention Rule That Protects Our Budget

I learned this the hard way earlier in my career. We bought a machine because it was available quickly and priced like a bargain. We skipped the test phase. Six months later, the utilization rate was below break-even, staff were trained inconsistently, and the system was taking up space instead of paying rent. The fix cost more than the savings.

Five minutes of verification beats five days of correction. That sounds obvious, but when a sales rep is waiting at the front desk and the clinic director wants an answer by Friday, the pressure is real. A checklist removes some of that pressure. It gives me a reason to say “not yet” without apologizing.

So, is laser resurfacing safe for all skin types? My answer is still not by default. It can be safe for many people, including patients with darker skin, when the evidence, device, training, and follow-up are aligned. That is a clinical decision, not a marketing slogan. The right vendor understands why I ask for proof. The wrong vendor just wants me to stop asking.

And when I do approve another device—even a Solta Medical system I already trust—it goes through the same checklist. The logo does not skip the process. It just makes the process easier.